SCENESSE® presented at ICPP in Milan
CLINUVEL PHARMACEUTICALS LTD today announced that safety and effectiveness data from...
Read More
CLINUVEL Notification of Dividend/Distribution
Download Notification of Dividend/Distribution
Read More
CLINUVEL Clarifies ex-Dividend Date
In relation to the dividend announcement earlier today, CLINUVEL PHARMACEUTICALS LTD...
Read More
CLINUVEL Declares Final Dividend
CLINUVEL PHARMACEUTICALS LTD is pleased to announce that it will issue...
Read More
Appendix 4E and Preliminary Financial Report
CLINUVEL PHARMACEUTICALS LTD (CLINUVEL), a global biopharmaceutical company focused on developing...
Read More
CLINUVEL program discussed at Light and Life 2019 Conference
CLINUVEL PHARMACEUTICALS LTD today announced that its program in systemic photoprotection...
Read More
CLINUVEL Newsletter - August 2019
Dear patients, shareholders, friends, In this News Communiqué VI for the...
Read More
Appendix 4C
CLINUVEL PHARMACEUTICALS LTD, a global biopharmaceutical company focused on developing and delivering...
Read More
Change in Composition of Audit & Risk Committee
CLINUVEL PHARMACEUTICALS LTD today announced that non-executive Director, Willem Blijdorp has...
Read More
CLINUVEL Newsletter - July 2019
In this Communiqué we turn our attention to the most recent...
Read More
CLINUVEL INCLUDED IN S&P/ASX 200 INDEX
CLINUVEL INCLUDED IN S&P/ASX 200 INDEX 14 June 2019 Download PDF ...
Read More
Lapse and forfeit of Unlisted Conditional Performance Rights
Melbourne, Australia 5 June 2019 Download PDF
Read More